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1. Introduction 
Most of the enzyme-immunoassays described in 
the literature employ enzyme-labelled antigen or 
hapten [l-8]. A few use enzyme-labelled anti-anti- 
body (anti-IgG*) [8,9]. Enzyme-labelled antibodies 
against the substance to be determined, provide a 
third tool for enzyme-immunoassay. 
In this report we describe two methods for the 
assay of human chorionic gonadotrophin (HCG), 
which employ anti-HCG labelled with horse-radish 
peroxidase (HRP). The methods are analogous to the 
‘immunoradiometric’ [lo] and the ‘sandwich’ [ 1 I] 
radioimmunoassays. Their sensitivities and the econo- 
my of reagents are compared with those of the Dasp 
enzyme-immunoassay for HCG, which employs HRP- 
labelled HCG. The latter method has been shown to 
be markedly more sensitive than the corresponding 
solid-phase assay [ 11. 
2. Materials and methods 
2. I. Materials 
HCG was prepared by Van Hell et al. [ 121, ac- 
cording to previously described procedures. Antisera 
against highly purified HCG were raised in rabbits as 
described previously [ 131. HRP, grade IV, was bought 
from Miles-Seravac, Maidenhead, Berks., England. 
*Abbreviations used: IgG = immunoglobulin G; HCG: human 
chorionic gonadotrophin; HRP: horse-radish peroxidase; 
Dasp: double antibody solid phase. 
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Glutamldehyde was bought from Schuchardt, Munich, 
W. Germany, as a 25% aqueous solution. Dasp@ anti- 
rabbit (sheep antibodies against rabbit IgG, covalently 
linked to cellulose) is a product of Organon Teknika, 
Oss, The Netherlands. 
2.2. Preparation of immunosorbents 
HCG-Sepharose was prepared by coupling highly 
purified HCG (approx. 10 000 IU/mg by bioassay) 
to CNBr-activated Sepharose 4B according to Porath 
et al. [ 141. (Anti-HCG)-cellulose was prepared by 
coupling the IgG fraction of anti-HCG serum (pre- 
pared by precipitation with 180 mg/ml of solid 
anhydrous Naa SO4 at room temperature) to cellulose 
according to the Gurvich method [ 151. 
2.3. Preparation of antibodies to HCG 
Anti-HCG serum (diluted with 9 volumes 0.05 M 
Na-citrate, pH 5.0) was passed through a column con- 
taining sufficient HCG-Sepharose to bind approxi- 
mately half of the antibodies applied. After washing 
until A $i&rr was less than 0.025, the antibodies 
were eluted with 0.3 M glycine-HCI (PH 3.0). The 
eluate was immediately adjusted to pH 5-7 with 
2 M NaOH, and concentrated by ultrafiltration to a 
protein content of approx. 5 mg/ml. All procedures 
were carried out at room temperature. 
2.4. Preparation of (anti-HCG)-HRP conjugates 
Antibodies to HCG were coupled to HRP using 
two different methods: (A) One-step method [17]. 
A solution containing 5 mg/ml of antibody, 5 mg/ml 
of HRP and 0.2% glutaraldehyde in phosphate-citrate 
buffer @H 7.0) was shaken for 2 hr at room temper- 
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ature, centrifuged for 10 min at 1000 g to remove 
insolubilized protein and passed over a Sephadex G-SO 
column to remove unreacted glutaraldehyde; (B) Two- 
step method. This is a modification [ 171 of the pro- 
cedure of Avrameas and Ternynck [ 161. HRP was 
dissolved (30 mg/ml) in 0.05 M phosphate-citrate 
buffer (pH 7.0) containing 2% glutaraldehyde and 
incubated for 18 hr at room temperature. Unreacted 
glutaraldehyde was removed by gel filtration on 
Sephadex G-50. The HRP-containing eluate was 
diluted to a concentration of 2 mg/ml. 0.3 ml of this 
solution was mixed with 0.2 ml (anti-HCG) solution 
(5 mg/ml) and incubated for 2 hr at room tempera- 
ture. 
The reaction products of both coupling methods 
were purified by centrifugation on a linear 20-60% 
sucrose gradient at 281 OOOg for 16 hr, as described 
previously [ 11. 
2.5. Preparation of HCG-HRP conjugates 
These conjugates were prepared either by a one- 
step or a two-step method. The one-step method has 
been described previously [ 11. In the two-step proce- 
dure (a modification of the procedure of Avrameas 
and Ternynck [ 16]), 10 mg HRP were dissolved in 
1 ml phosphate-citrate buffer (pH 7.0) containing 
1% glutaraldehyde and incubated for 18 hr at room 
temperature. 
Unreacted glutaraldehyde was removed by gel fi- 
tration on Sephadex G-50. The HRPcontaining eluate 
was concentrated to 1 ml by ultrafiltration. 2.5 mg:, 
HCG were dissolved in the concentrate, which was 
then incubated for 2 hr at room temperature. The 
reaction products of both methods were purified by 
ultracentrifugation (see section 2.4). 
2.6. Enzyme-immunoassay procedure 
2.6.1. Immunoenzymometric method 
This method is analogous to the immunoradio- 
metric method of Miles of Hales [lo]. 0.6 ml of 
sample (containing HCG) was incubated for 30 min 
with 0.1 ml of diluted* (anti-HCG)-HRP conjugate. 
* The amount of conjugate in the incubation mixtures was 
so chosen that, in the absence of other immunoreagents, it 
would give an A ’ cm 450 nm of approx. 0.4 in the final enzyme 
assay. 
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Then 0.3 ml HCG-Sepharose suspension (in a con- 
centration which allowed binding of all the added 
conjugate) was added, the mixture shaken for 2 hr 
and centrifuged for 5 min at 1000 g. The amounts of 
HRP-activity in the supernatant was measured as des- 
cribed previously [ 11. 
2.6.2. Sandwich method 
The analogous radioimmunoassay was described 
by Wide [l I]. 0.6 ml of sample (containing HCG) 
was shaken for 2 hr with 0.3 ml (anti-HCG)-cellulose 
suspension (in a concentration related to the expected 
highest HCG-concentration in the test sample [ 171). 
0.1 ml of diluted* (anti-HCG)-HRP conjugate was 
added, the mixture shaken for 2 hr and centrifuged 
for 5 min at 1000 g. The amount of HRP-activity in 
the supernatant was measured as described previously 
Ill. 
2.6.3. Dasp method 
The method was described in detail in a previous 
article [ 11.0.5 ml of sample (containing HCG) was 
incubated for 30 min with 0.1 ml of suitably diluted 
antiserum. 0.1 ml of diluted* HCG-HRP conjugate 
was added, and the mixture incubated for 30 min. 
After adding 0.3 ml of a Dasp anti-rabbit suspension, 
the mixture was shaken for 2 hr, and centrifuged for 
5 min at 1OOOg. The HRP-activity in the supernatant 
was measured as described previously [ 11. 
3. Results and discussion 
Labelled-antibody methods have one obvious ad- 
vantage: every antibody -HRP conjugate can be pre- 
pared by the same method (provided that the anti- 
bodies are evoked in the same animal species). How- 
ever, the need to pr,pare the antibodies by affinity 
chromatography forms a disadvantage. 
In order to compare the sensitivities, we tested 
the effect of a dilution series of HCG in the three 
assays described in section 2.6. This experiment was 
performed with conjugates prepared by both the one- 
step and the two-step methods. The antibodies used 
- in conjugates, in immunosorbent and in solution - 
were all from the same antiserum. Different batches 
of HCG, of comparable purity, were used for the 
preparation of antiserum, immunosorbent and con- 
jugates. The response curves are shown in fig. 1. 
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Fig. 1, Dose-response curves in different enzyme-immuno- 
assays for HCG. 
1. immunoenzymometric assay 
I 
employing (anti-HCG)- 
2. sandwich assay HRP conjugates 
3. Dasp assay employing HCG-HRP conjugates 
In part A. conjugates prepared by the one-step method were 
used. In part B. conjugates prepared by the two-step method 
were used. 
Part A shows the curves obtained with the conjugates 
prepared by the one-step method, part B those 
obtained with conjugates prepared by the two-step 
method. The difference between one-step and two- 
step conjugates lies in their composition: the molar 
antibody (or HCG)/HRP ratio is less than one for 
one-step conjugates [ 181. but at least equals and pos- 
sibly exceeds one for two-step conjugates [ 161. This 
difference should not affect the sensitivity of the 
Dasp and the sandwich assays, but the immuno- 
enzymometric assay should be less sensitive when 
using one-step conjugates than when using two-step 
conjugates [ 171. This was confirmed by the experi- 
mental findings: Curves A2 and B2 are close together, 
like curves A3 and B3, but curves Al and Bl differ 
markedly. Using a two-step conjugate, it may be 
expected that the sandwich assay is about as sensitive 
as the Dasp assay and the immunoenzymometric 
assay [ 171. It was found, however, that the andwich 
assay (curve B2) was IO-20 times less sensitive than 
the others (curves B 1 and B3). This may be caused 
by steric hindrance, since the binding of the con- 
jugate to the antigen occurs at the surface of the 
immunosorbent in the sandwich assay, but in solution 
in the other assays. Another reason may be that the 
affinity of the antibodies may be affected (possibly 
to different degrees) by coupling to HRP and to cel- 
lulose. 
A rough calculation indicates that in the two-step 
procedure the amounts of HRP required to obtain 
reagents for the same number of HCG determinations, 
are approximately equal for all three assays. The 
sandwich assay, however, requires 3 times as much 
HCG as the other assays. In addition, considerably 
more antibodies are required for the labelled-antibody 
methods. In conclusion, in terms of sensitivity and 
economy, labelled-antibody methods are not prefer- 
able to the Dasp enzyme-immunoassay using HCG- 
HRP conjugates. 
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